Clinical research across Eastern Europe
Clinical Trials in Georgia
Regional expertise, established site relationships and efficient operational support for studies in Georgia.
Discuss your study
Why conduct clinical research in Georgia?
- Experienced investigators and sites familiar with international, ICH-GCP-aligned studies.
- Recruitment potential across multiple therapeutic areas.
- Operational costs that may be competitive with Western European markets.
- National regulatory and ethics pathways supported by local expertise.
Georgia clinical research snapshot
These charts are retained from the original IRIS CRO website. They are historical snapshots rather than current market statistics; the clinical-trial charts explicitly cover January 2021 to January 2022.
Before using these figures in a proposal or feasibility assessment, verify the current data and source methodology for the relevant study.
Regulatory and ethics framework in Georgia
Georgia is not part of the EU CTIS system, so studies follow national regulatory and ethics procedures, including arrangements for the import of investigational product. We confirm the current requirements for your protocol during feasibility.
Typical start-up workstreams in Georgia
- Country feasibility: review of the protocol against local standard of care, investigator interest and patient availability.
- Regulatory and ethics submissions: preparation, translation and tracking of submission packages and responses to authority questions.
- Contracts and budgets: site agreements, budget negotiation and insurance documentation.
- Site activation: qualification, training, essential documents and investigational product logistics.
- Conduct and oversight: monitoring, issue escalation and sponsor reporting through close-out.
Timelines, authority requirements and site capacity change over time, so we confirm current conditions for your protocol during feasibility rather than quoting generic figures.
Multi-country studies
Many sponsors combine Georgia with neighbouring countries to reach enrolment targets.